AeroLeads people directory · profile
Joanne Sloan Lancaster Email & Phone Number
VP Clinical Development and TA Leader, Immunology
at
Neurocrine Biosciences
LinkedIn matched
✓ Verified Jul 2026
3 data sources
Profile completeness 86%
Current company
Role
VP Clinical Development and TA Leader, Immunology
Location
San Francisco Bay Area, United States
Company size
Who is Joanne Sloan Lancaster? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Joanne Sloan Lancaster is listed as VP Clinical Development and TA Leader, Immunology at Neurocrine Biosciences, a with 1980 employees, based in San Francisco Bay Area, United States. AeroLeads shows a matched LinkedIn profile for Joanne Sloan Lancaster.
Joanne Sloan Lancaster previously worked as VP Clinical Development and TA Leader, Neuroinflammation at Neurocrine Biosciences and Vice President, Clinical Development at Ngm Biopharmaceuticals. Joanne Sloan Lancaster holds Post Doctorate, Immunology from National Institutes Of Health.
Company email context
Email format at Neurocrine Biosciences
This section adds company-level context without repeating Joanne Sloan Lancaster's masked contact details.
Neurocrine Biosciences
Review company-level records connected to Joanne Sloan Lancaster before choosing the right outreach path.
Profile bio
About Joanne Sloan Lancaster
As a seasoned and results-driven executive, I bring expertise in spearheading successful clinical trials and leading multidisciplinary teams in the pharmaceutical and biotechnology industries. My passion lies in advancing healthcare through innovative clinical development strategies, ensuring the successful progression of drug candidates from concept through development and to market.Throughout my career, I have consistently demonstrated a commitment to advancing clinical development initiatives. Having held key leadership roles in prominent pharmaceutical companies, I have successfully navigated complex regulatory landscapes, optimized trial designs, and facilitated seamless collaboration between cross-functional teams. I am dedicated to driving innovation in clinical development. I have championed the integration of cutting-edge technologies, data analytics, and real-world evidence into trial protocols, enhancing efficiency and decision-making processes. Embracing a forward-thinking mindset, I constantly explore novel methodologies to accelerate timelines, reduce costs, and enhance the overall quality of clinical trials.Navigating the evolving regulatory landscape is paramount in clinical development. I possess a deep understanding of global regulatory requirements and maintain a proactive approach to compliance. My experience includes successful interactions with regulatory agencies, ensuring smooth regulatory submissions, approvals, and post-marketing commitments.In addition to holding a PhD in immunology, I have deep experience in developing drugs for indications within immunology/autoimmunity, oncology (immune-based and other targeted therapeutics), neurodegeneration, diabetes, kidney disease, metabolic diseases and chronic pain.In summary, I have a passion for innovation, and a commitment to improving patient lives through strategic and impactful clinical development.
Current workplace
Joanne Sloan Lancaster's current company
Company context helps verify the profile and gives searchers a useful next step.
Neurocrine Biosciences
7 roles
Joanne Sloan Lancaster work experience
A career timeline built from the work history available for this profile.
Vp Clinical Development And Ta Leader, Neuroinflammation
Vice President, Clinical Development
• Championed pharmacometrics modeling and simulations to justify a single dose level for an orphan disease, eliminating the need for a dose-finding study, thereby accelerating time to market.• Leveraged creativity and flexibility in oncology study design and execution, enabling data-driven pivots to generate decisive data rapidly and cost-effectively and enable timely program redirection.• Repurposed a clinical asset to a new therapeutic area based on emerging science, utilizing efficient study design to rapidly generate data and assess potential growth opportunity for the portfolio.
Vice President And Head, Drug Development, Program Leadership
Calico Labs
• Successfully built a seasoned program leadership group, streamlining portfolio progression and accelerating drug development.• Built and executed an indication selection framework, prioritizing and streamlining development plans that accelerated programs, maximized efficiency, and propelled portfolio advancement.• Championed and led various disease-related summits with a pharmaceutical co-development partner, leveraging complementary expertise and advancing discovery and development efforts for new aging indication opportunities.
Feb 2020 - Mar 2022
Global Head, Exploratory Medicine And Clinical Pharmacology: Immunology And Oncology
• Rebuilt and revitalized the group during a challenging phase of significant attrition, transforming it into a high-performing team that delivered ~ 35 clinical study packages in 2 years, including pivotal data packages to secure approvals of oncology indications or markets, approval of improved formulation for key psoriasis drug (Taltz) to recapture market, inform dose for new drug approval (Mirikizumab, Ulcerative Colitis), and portfolio advancement of multiple early assets.• Cultivated a strong partnership with Oncology Early Development group and steered the generation of germane preclinical data packages to inform clinical dose ranges and define quantitative pharmacologic exposure-response assessments, thereby capturing an early read on the clinical translation of the drugs’ mechanisms and activity.
Jan 2018 - Jan 2020
Clinical. Translational And Program Leader, Chorus Clinical Development
• Pioneered and drove the early clinical development of Taltz, navigating through post-TeGenero regulatory complexities to achieve market success.• Secured unanimous backing and EU Orphan Drug Designation for a novel drug candidate through persuasive advocacy and clinical insight, securing the tax credit and intellectual property incentives afforded by the designation.• Delivered decisive preclinical, translational and early clinical data for over a dozen compounds across various therapeutic areas, uncovering attributes and risks that enabled go and no-go decisions, maximizing the value of the portfolio.
Oct 2005 - Dec 2017
Principal Scientist
Jul 1998 - Oct 2005
3 education records
Joanne Sloan Lancaster education
Post Doctorate, Immunology
National Institutes Of Health
Phd, Immunology
Bachelor Of Science - Bs
FAQ
Frequently asked questions about Joanne Sloan Lancaster
Quick answers generated from the profile data available on this page.
What company does Joanne Sloan Lancaster work for?
Joanne Sloan Lancaster works for Neurocrine Biosciences.
What is Joanne Sloan Lancaster's role at Neurocrine Biosciences?
Joanne Sloan Lancaster is listed as VP Clinical Development and TA Leader, Immunology at Neurocrine Biosciences.
Where is Joanne Sloan Lancaster based?
Joanne Sloan Lancaster is based in San Francisco Bay Area, United States while working with Neurocrine Biosciences.
What companies has Joanne Sloan Lancaster worked for?
Joanne Sloan Lancaster has worked for Neurocrine Biosciences, Ngm Biopharmaceuticals, Calico Labs, and Eli Lilly And Company.
How can I contact Joanne Sloan Lancaster?
You can use AeroLeads to view verified contact signals for Joanne Sloan Lancaster at Neurocrine Biosciences, including work email, phone, and LinkedIn data when available.
What schools did Joanne Sloan Lancaster attend?
Joanne Sloan Lancaster holds Post Doctorate, Immunology from National Institutes Of Health.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial